Nile Pharmaceuticals Reports 23% Slump in H1 Net Profit

Egypt-based Nile Pharmaceuticals and Chemical Industries published Sunday its first half results showing a decline in net profit by 23% year-on-year to register EGP 17 million.

In H1/13, the company (NIPH.CA on the Egyptian Exchange) posted a net profit of EGP 22.3 million.